| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $510K | — | +147.6% |
| R&D Expense | $822K | — | -65.5% |
| SG&A Expense | $3.4M | — | +40.3% |
| Operating Income | -$4.8M | — | +7.5% |
| Interest Expense | $178K | — | — |
| Pre-tax Income | -$5.0M | — | +3.3% |
| Net Income | -$5.0M | — | +3.3% |
| EPS (Basic) | -$3.13 | — | -328.8% |
| EPS (Diluted) | -$3.13 | — | -328.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.3M | +937.5% | +573.2% |
| Accounts Receivable | $1.5M | — | — |
| Inventory | $1.8M | +0.6% | -21.3% |
| Current Assets | $37.9M | +660.0% | +448.1% |
| Total Assets | $604.5M | — | +7683.7% |
| Current Liabilities | $17.7M | +100.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | +0.3% |
| Capital Expenditures | $6.2M | — | — |
| Investing Cash Flow | $30.4M | — | — |
| Financing Cash Flow | $350K | — | -53.8% |
| Free Cash Flow | -$10.5M | — | — |
| +334.0% |
| Total Liabilities | $28.5M | +213.9% | +528.4% |
| Stockholders' Equity | $576.0M | — | — |